Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6709)
All Articles published online
|
Publishing Process of This Article
|
Feb 7, 2020 (publication date) through Mar 10, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zheng H, Wang JJ, Yang XR, Yu YL. Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells. World J Gastroenterol 2020; 26(5): 499-513 [PMID: 32089626 DOI: 10.3748/wjg.v26.i5.499] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i5/499.htm |
| Number | Citing Articles |
| 1 |
Shantanu Gupta, Pritam Kumar Panda, Wei Luo, Ronaldo F. Hashimoto, Rajeev Ahuja. Network analysis reveals that the tumor suppressor lncRNA GAS5 acts as a double-edged sword in response to DNA damage in gastric cancer. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-21492-x
|
| 2 |
Doaa Fathi, Mohammed S. Elballal, Ahmed E. Elesawy, Ahmed I. Abulsoud, Ahmed Elshafei, Elsayed G.E. Elsakka, Ahmed Ismail, Hesham A. El-Mahdy, Mahmoud A. Elrebehy, Ahmed S. Doghish. An emphasis on the interaction of signaling pathways highlights the role of miRNAs in the etiology and treatment resistance of gastric cancer. Life Sciences 2023; 322: 121667 doi: 10.1016/j.lfs.2023.121667
|
| 3 |
Barbara Marengo, Alessandra Pulliero, Maria Valeria Corrias, Riccardo Leardi, Emanuele Farinini, Gilberto Fronza, Paola Menichini, Paola Monti, Lorenzo Monteleone, Giulia Elda Valenti, Andrea Speciale, Patrizia Perri, Francesca Madia, Alberto Izzotti, Cinzia Domenicotti. Potential Role of miRNAs in the Acquisition of Chemoresistance in Neuroblastoma. Journal of Personalized Medicine 2021; 11(2): 107 doi: 10.3390/jpm11020107
|
| 4 |
Bardia Mortezagholi, Kamyar Nasiri, Emad Movahed, Esmaeel Dadgar, Seyedeh Tabasom Nejati, Pardis Hassani, Mahla Esfahaniani, Sona Rafieyan. MiR‐34 by targeting p53 induces apoptosis and DNA damage in paclitaxel‐resistant human oral squamous carcinoma cells. Chemical Biology & Drug Design 2023; 102(2): 285 doi: 10.1111/cbdd.14240
|
| 5 |
Shaobo Zhang, Haoqi Miao, Tian Han, Xiangzhen Wu, Chao Liang, Jian Qian, Pengfei Shao. MCM8 promotes NR4A1-mediated E2F1 transcription and facilitates renal cell carcinoma through enhancing aerobic glycolysis. Cell Biology and Toxicology 2025; 41(1) doi: 10.1007/s10565-025-10002-0
|
| 6 |
Shanshan Wang, Ming-Yue Li, Yi Liu, Alexander C Vlantis, Jason YK Chan, Lingbin Xue, Bao-Guang Hu, Shucai Yang, Mo-Xian Chen, Shaoming Zhou, Wei Guo, Xianhai Zeng, Shuqi Qiu, C Andrew van Hasselt, Michael CF Tong, George G Chen. The role of microRNA in cisplatin resistance or sensitivity. Expert Opinion on Therapeutic Targets 2020; 24(9): 885 doi: 10.1080/14728222.2020.1785431
|
| 7 |
Fatimat Kipkeeva, Tatyana Muzaffarova, Alexandra Korotaeva, Maxim Nikulin, Kristina Grishina, Danzan Mansorunov, Pavel Apanovich, Alexander Karpukhin. MicroRNA in Gastric Cancer Development: Mechanisms and Biomarkers. Diagnostics 2020; 10(11): 891 doi: 10.3390/diagnostics10110891
|
| 8 |
Shengbo Li, Xiaofan Yang, Wenqing Li, Zhenbing Chen. Comprehensive Analysis of E2F Family Members in Human Gastric Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.625257
|
| 9 |
Ran Zhang, Yueyue Zhang, Liumei Tang, Yixing Xu, Hao Li, Xueping Jiang, Xiangdong Xin, Zhongzheng Gui. Ptxplatin: a multifunctional Pt(iv) antitumor prodrug. Inorganic Chemistry Frontiers 2022; 9(20): 5252 doi: 10.1039/D2QI01398C
|
| 10 |
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, Farid Hashemi, Ebrahim Rahmani Moghadam, Marzieh Owrang, Fardin Hashemi, Pooyan Makvandi, Mohammad Ali Sheikh Beig Goharrizi, Masoud Najafi, Haroon Khan. Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators. Cellular Signalling 2021; 78: 109871 doi: 10.1016/j.cellsig.2020.109871
|
| 11 |
Fatemeh Dashti, Seyed Mohammad Ali Mirazimi, Nikta Rabiei, Reza Fathazam, Negin Rabiei, Haleh Piroozmand, Massoud Vosough, Neda Rahimian, Michael R. Hamblin, Hamed Mirzaei. The role of non-coding RNAs in chemotherapy for gastrointestinal cancers. Molecular Therapy - Nucleic Acids 2021; 26: 892 doi: 10.1016/j.omtn.2021.10.004
|
| 12 |
Maddalen Otaegi-Ugartemendia, Ander Matheu, Estefania Carrasco-Garcia. Impact of Cancer Stem Cells on Therapy Resistance in Gastric Cancer. Cancers 2022; 14(6): 1457 doi: 10.3390/cancers14061457
|
| 13 |
Xianzhe Yu, Yin Zhang, Fengming Luo, Qinghua Zhou, Lingling Zhu. The role of microRNAs in the gastric cancer tumor microenvironment. Molecular Cancer 2024; 23(1) doi: 10.1186/s12943-024-02084-x
|
| 14 |
Yan Fu, Cheng’en Hu, Peizhun Du, Guangjian Huang, Jie Mei. E2F1 Maintains Gastric Cancer Stemness Properties by Regulating Stemness-Associated Genes. Journal of Oncology 2021; 2021: 1 doi: 10.1155/2021/6611327
|
| 15 |
Abdulrahman Qais Khaleel, Mohammad Y. Alshahrani, Jasur Alimdjanovich Rizaev, H. Malathi, Seema Devi, Atreyi Pramanik, Yasser Fakri Mustafa, Ahmed Hjazi, Ismoilova Muazzamxon, Beneen Husseen. siRNA-based strategies to combat drug resistance in gastric cancer. Medical Oncology 2024; 41(11) doi: 10.1007/s12032-024-02528-w
|
| 16 |
Si-Ran Wu, Qiong Wu, Yong-Quan Shi. Recent advances of miRNAs in the development and clinical application of gastric cancer. Chinese Medical Journal 2020; 133(15): 1856 doi: 10.1097/CM9.0000000000000921
|
| 17 |
Junjiang Fu, Saber Imani, Mei-Yi Wu, Ray-Chang Wu. MicroRNA-34 Family in Cancers: Role, Mechanism, and Therapeutic Potential. Cancers 2023; 15(19): 4723 doi: 10.3390/cancers15194723
|
| 18 |
Chongli Zhang, Yong Cui, Guannan Wang, Wugan Zhao, Haiyu Zhao, Xuejie Huang, Min Zhang, Wencai Li, Osamah Ibrahim Khalaf. Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Clear Cell Renal Cell Carcinoma. Journal of Healthcare Engineering 2021; 2021: 1 doi: 10.1155/2021/5790416
|
| 19 |
Zun-Yan Zhou, Ji-Yuan Yang, Cheng-Ze Shao, Fei Luo, Wei Du. Positive regulation of ataxia-telangiectasia-mutated protein (ATM) by E2F transcription Factor 1 (E2F-1) in cisplatin-resistant nasopharyngeal carcinoma cells. World Journal of Surgical Oncology 2022; 20(1) doi: 10.1186/s12957-022-02546-w
|
| 20 |
Ying Liu, Xiang Ao, Guoqiang Ji, Yuan Zhang, Wanpeng Yu, Jianxun Wang. Mechanisms of Action And Clinical Implications of MicroRNAs in the Drug Resistance of Gastric Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.768918
|
| 21 |
Soudeh Ghafouri-Fard, Hamed Shoorei, Atefe Abak, Sayed Haidar Abbas Raza, Martin Pichler, Mohammad Taheri. Role of non-coding RNAs in modulating the response of cancer cells to paclitaxel treatment. Biomedicine & Pharmacotherapy 2021; 134: 111172 doi: 10.1016/j.biopha.2020.111172
|
| 22 |
Pía Loren, Nicolás Saavedra, Kathleen Saavedra, Nadine De Godoy Torso, Marília Berlofa Visacri, Patricia Moriel, Luis A. Salazar. Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.831099
|
| 23 |
Masoud Najafi, Shima Tavakol, Ali Zarrabi, Milad Ashrafizadeh. Dual role of quercetin in enhancing the efficacy of cisplatin in chemotherapy and protection against its side effects: a review. Archives of Physiology and Biochemistry 2022; 128(6): 1438 doi: 10.1080/13813455.2020.1773864
|
| 24 |
Yong Li, Hui-Qin Huang, Zheng-Hui Huang, Nan-Ding Yu, Xiang-Li Ye, Mei-Chen Jiang, Li-Min Chen. SNHG15 enhances cisplatin resistance in lung adenocarcinoma by affecting the DNA repair capacity of cancer cells. Diagnostic Pathology 2023; 18(1) doi: 10.1186/s13000-023-01291-2
|